Wynzora

Wynzora is a topical corticosteroid and vitamin D analogue combination used for plaque psoriasis relief. This prescription-free cream provides targeted skin treatment with dual-action anti-inflammatory benefits. Wynzora supports skin healing and reduces redness, scaling, and itching associated with mild to moderate psoriasis.

Wynzora cream is used to treat mild to moderate plaque psoriasis in adults. It combines betamethasone, a corticosteroid that reduces inflammation and itching, with calcipotriol, a vitamin D analogue that helps normalize skin cell growth. This combination therapy is designed for application to affected skin areas to provide relief from psoriatic symptoms.

Wynzora works by reducing inflammation and slowing the excessive growth of skin cells that characterize psoriasis. The cream helps restore the skin barrier and alleviate symptoms such as redness, scaling, and itching. Users may notice improved skin texture and reduced flare-ups with consistent application.

Wynzora is for external use only and should not be applied to broken or infected skin. Avoid contact with eyes, mouth, or mucous membranes. Wash hands before and after application unless treating hands. Do not cover treated areas with bandages or dressings unless directed. Keep out of reach of children and pets.

No specific drug interactions have been reported with Wynzora cream. However, avoid using other topical medications on the same area unless advised by a healthcare provider. Concurrent use of strong corticosteroids or vitamin D analogues may increase the risk of side effects. Consult a doctor if using other skin treatments.